Crumlin, United Kingdom

Ashley Diane Martin

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Randox Laboratories Limited, University of the West of England, Bristol. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashley Diane Martin. Retrieved from https://idiyas.com/inventor/ashley-diane-martin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ashley Diane Martin

Introduction

Ashley Diane Martin is a notable inventor based in Crumlin, GB. She has made significant strides in the field of biotechnology, particularly in developing methods to assess drug sensitivity in cell lines and patient samples. Her work has the potential to impact therapeutic strategies in medicine.

Latest Patents

Ashley holds a patent for a method titled "Determining the sensitivity of a cell to a drug." This invention provides an in vitro approach for determining the resistance or sensitivity of a cell line or patient sample to a deoxyribonucleoside kinase-dependent drug. The method involves several steps, including treating a sample with the drug, lysing the cells, and measuring bioluminescence to assess drug sensitivity.

Career Highlights

Throughout her career, Ashley has worked with reputable organizations, including Randox Laboratories Limited and the University of the West of England. Her experience in these institutions has contributed to her expertise in the field of drug sensitivity testing.

Collaborations

Ashley has collaborated with notable colleagues such as Vyvyan Clare Salisbury and Habib Mahmoud Alloush. These partnerships have likely enriched her research and innovation efforts.

Conclusion

Ashley Diane Martin's contributions to biotechnology and her innovative patent demonstrate her commitment to advancing medical research. Her work continues to pave the way for improved drug sensitivity assessments, which can lead to better patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…